Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

DKN-01 Inhibition in Advanced Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03645980
Recruitment Status : Recruiting
First Posted : August 24, 2018
Last Update Posted : October 22, 2020
Leap Therapeutics, Inc.
Information provided by (Responsible Party):
Dr. J. U. Marquardt, Johannes Gutenberg University Mainz

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 31, 2021
Estimated Study Completion Date : August 31, 2022